Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments
暂无分享,去创建一个
M. M. Ahmed | S. S. Imam | A. Zafar | S. Gilani | M. Rizwanullah | Sultan M. Alshehri | M. N. bin Jumah | S. Imam | M. N. Bin Jumah
[1] Linjie Wu,et al. Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats , 2022, Polymers.
[2] M. Hashemi,et al. Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization , 2022, Applied Biochemistry and Biotechnology.
[3] S. S. Imam,et al. Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles , 2022, Pharmaceutics.
[4] S. S. Imam,et al. Formulation of Piperine Nanoparticles: In Vitro Breast Cancer Cell Line and In Vivo Evaluation , 2022, Polymers.
[5] P. R. Vuddanda,et al. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications. , 2022, Critical reviews in therapeutic drug carrier systems.
[6] Deepa Geethakumari,et al. Folate Functionalized Chitosan Nanoparticles as Targeted Delivery Systems for improved anticancer efficiency of Cytarabine in MCF-7 human breast cancer cell lines. , 2021, International journal of biological macromolecules.
[7] M. Ghoneim,et al. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges , 2021, Pharmaceutics.
[8] M. Ghoneim,et al. Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives , 2021, Polymers.
[9] Tianyang Ren,et al. Bioadhesive poly(methyl vinyl ether-co-maleic anhydride)-TPGS copolymer modified PLGA/lipid hybrid nanoparticles for improving intestinal absorption of cabazitaxel. , 2021, International journal of pharmaceutics.
[10] Satish K. Sharma,et al. Thymoquinone loaded chitosan - Solid lipid nanoparticles: Formulation optimization to oral bioavailability study , 2021 .
[11] H. Smyth,et al. Improved intestinal absorption and oral bioavailability of astaxanthin via poly (ethylene glycol)-graft-chitosan nanoparticle: preparation, in vitro evaluation and pharmacokinetics in rats. , 2021, Journal of the science of food and agriculture.
[12] S. Mir,et al. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies , 2021, Nanotechnology.
[13] Ruizhi Zhao,et al. Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel , 2021, Asian journal of pharmaceutical sciences.
[14] P. Opanasopit,et al. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery , 2021, Pharmaceutical development and technology.
[15] Xiaoyong Song,et al. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability , 2021, Drug delivery.
[16] Rizwanullah,et al. Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments , 2020, Coatings.
[17] J. Venugopal,et al. PEGylated Lipid Polymeric Nanoparticle–Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation , 2020, AAPS PharmSciTech.
[18] R. Harwansh,et al. Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs. , 2020, Critical reviews in oncology/hematology.
[19] Leonardo M. B. Ferreira,et al. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route , 2020, Drug Delivery and Translational Research.
[20] V. Jain,et al. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[21] S. Mir,et al. Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment , 2020 .
[22] Mahfoozur Rahman,et al. Polymer-Lipid Hybrid Systems: Scope of Intravenous-To-Oral Switch in Cancer Chemotherapy , 2020 .
[23] S. Reis,et al. Mucoadhesive and pH responsive fucoidan-chitosan nanoparticles for the oral delivery of methotrexate. , 2020, International journal of biological macromolecules.
[24] D. Mooney,et al. A nanoparticle’s pathway into tumours , 2020, Nature Materials.
[25] S. Chattopadhyay,et al. Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[26] S. Takka,et al. Antıtumor actıvıty of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNS) ın vıtro and ın vıvo. , 2020, International journal of pharmaceutics.
[27] S. Mitragotri,et al. Permeation of nanoparticles across the intestinal lipid membrane: dependence on shape and surface chemistry studied through molecular simulations. , 2020, Nanoscale.
[28] D. Chellappan,et al. Nanocarriers: more than tour de force for thymoquinone , 2020, Expert opinion on drug delivery.
[29] E. Davies,et al. Breast cancer , 2020, Medicine.
[30] Harshita,et al. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors. , 2020, Current pharmaceutical design.
[31] P. Mishra,et al. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines. , 2019, Materials science & engineering. C, Materials for biological applications.
[32] M. A. Mirza,et al. Formulation and evaluation of thymoquinone niosomes: application of developed and validated RP-HPLC method in delivery system , 2019, Drug Development and Industrial Pharmacy.
[33] M. Moghaddam,et al. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents. , 2019, Therapeutic delivery.
[34] Chandrakala,et al. Formulation of thymoquinone loaded chitosan nano vesicles: In-vitro evaluation and in-vivo anti-hyperlipidemic assessment , 2019, Journal of Drug Delivery Science and Technology.
[35] S. Kesari,et al. Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives , 2019, International journal of nanomedicine.
[36] J. Sousa,et al. Rethinking carbamazepine oral delivery using polymer‐lipid hybrid nanoparticles , 2019, International journal of pharmaceutics.
[37] S. Mousa,et al. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases , 2018, Nutrients.
[38] Wei Keat Ng,et al. Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice. , 2018, Nanomedicine.
[39] M. R. Mozafari,et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.
[40] Bhupinder Singh,et al. Chitosan-tailored lipidic nanoconstructs of Fusidic acid as promising vehicle for wound infections: An explorative study. , 2018, International journal of biological macromolecules.
[41] A. C. Jayasuriya,et al. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan‐alginate polyelectrolyte microparticles as a controlled drug delivery system , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[42] H. Gali-Muhtasib,et al. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. , 2018, Drug discovery today.
[43] S. Mir,et al. Phytochemical based nanomedicines against cancer: current status and future prospects , 2017, Journal of drug targeting.
[44] P. Rameshthangam,et al. Anticancer activity of silver and copper embedded chitin nanocomposites against human breast cancer (MCF-7) cells. , 2017, International journal of biological macromolecules.
[45] H. Santos,et al. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. , 2017, International journal of pharmaceutics.
[46] M. Raish,et al. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system. , 2017, Materials science & engineering. C, Materials for biological applications.
[47] C. Dora,et al. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. , 2017, Colloids and surfaces. B, Biointerfaces.
[48] Mingtao Ao,et al. PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency , 2017, Drug delivery.
[49] Sumathi Thangarajan,et al. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats. , 2016, Chemico-biological interactions.
[50] C. Prestidge,et al. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery , 2016, Expert opinion on drug delivery.
[51] Gajanand Sharma,et al. Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles. , 2016, Carbohydrate polymers.
[52] P. Fisher,et al. Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. , 2015, Molecular pharmaceutics.
[53] Ravi R. Patel,et al. Rationally developed core–shell polymeric-lipid hybrid nanoparticles as a delivery vehicle for cromolyn sodium: implications of lipid envelop on in vitro and in vivo behaviour of nanoparticles upon oral administration , 2015 .
[54] R. Tyagi,et al. Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate , 2015 .
[55] A. Hosseinzadeh Colagar,et al. Thymoquinone and its therapeutic potentials. , 2015, Pharmacological research.
[56] Ravi R. Patel,et al. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design , 2015, DARU Journal of Pharmaceutical Sciences.
[57] Neeraj Kumar,et al. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. , 2014, International journal of pharmaceutics.
[58] J. Morgado-Díaz,et al. Cytotoxic effects of Euterpe oleracea Mart. in malignant cell lines , 2014, BMC Complementary and Alternative Medicine.
[59] Mushir M. Ali,et al. Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies , 2013, Nanotechnology.
[60] Hsing-Wen Sung,et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. , 2013, Advanced drug delivery reviews.
[61] Lingxue Kong,et al. Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery , 2013, AAPS PharmSciTech.
[62] G. Mustafa,et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study , 2012, International journal of nanomedicine.
[63] S. Ostad,et al. Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[64] I. Warner,et al. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles , 2010, Nanotechnology.
[65] N. Peppas,et al. Mechanisms of solute release from porous hydrophilic polymers , 1983 .